BiddleKJadeJWilson-MorkehH, et al. (2025) The 2025 British Society for Rheumatology management recommendations for ANCA-associated vasculitis. Rheumatology64(8): 4470–4494. DOI: 10.1093/rheumatology/keaf240.
2.
ConradNMisraSVerbakelJY, et al. (2023) Incidence, prevalence, and co-occurrence of autoimmune disorders over time and by age, sex, and socioeconomic status: a population-based cohort study of 22 million individuals in the UK. The Lancet401(10391): 1878–1890. DOI: 10.1016/S0140-6736(23)00457-9.
3.
DasguptaBBorgFAHassanN, et al. (2010) BSR and BHPR guidelines for the management of polymyalgia rheumatica. Rheumatology49(1): 186–190. DOI: 10.1093/rheumatology/kep303a.
4.
DaviesKDuresENgWF (2021) Fatigue in inflammatory rheumatic diseases: current knowledge and areas for future research. Nature Reviews Rheumatology17: 651–664. DOI: 10.1038/s41584-021-00692-1.
5.
DentonCPDe LorenzisERoblinE, et al. (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology63(11): 2956–2975. DOI: 10.1093/rheumatology/keae394.
6.
EvdokimovDFrankJKlitschA, et al. (2019) Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Annals of Neurology86(4): 504–516. DOI: 10.1002/ana.25565.
7.
FiresteinGSMcInnesIBKoretzkyGA, et al. (2024) Firestein & Kelley’s Textbook of Rheumatology, 2-Volume Set, 12th edn.Elsevier.
8.
GilAMBarahona-CorreaJFlorezJB, et al. (2025) Risk of new onset of immune-mediated diseases after SARS-CoV-2 infection: a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism74: 152805. DOI: 10.1016/j.semarthrit.2025.152805.
9.
GlennonP (2024) Sjögren disease, new name, new guidelines: Key messages for primary care. InnovAiT17(11–12): 512–516. DOI: 10.1177/17557380241281472.
10.
GoebelAKrockEGentryC, et al. (2021) Passive transfer of fibromyalgia symptoms from patients to mice. The Journal of Clinical Investigation131(13): e144201. DOI: 10.1172/jci144201.
11.
MackieSLDejacoCAppenzellerS, et al. (2020) British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis. Rheumatology59(3): e1–e23. DOI: 10.1093/rheumatology/kez672.
12.
MurphyRMootsRJBroganP, et al. (2025) British Association of Dermatologists and British Society for Rheumatology living guideline for managing people with Behçets 2025. Rheumatology65(2): keaf521. DOI: 10.1093/rheumatology/keaf521.
13.
NICE (2015) Suspected cancer: recognition and referral. Available at: www.nice.org.uk/guidance/ng12 (accessed 7 January 2026).
14.
NICE (2019) Acute kidney injury: prevention, detection and management. Available at: www.nice.org.uk/guidance/ng148 (accessed 7 January 2026).
15.
PriceEJBenjaminSBombardieriM, et al. (2024) British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease. Rheumatology64(2): 409–439. DOI: 10.1093/rheumatology/keae152.
16.
RAIRDA (Rare Autoimmune Rheumatic Diseases Alliance) (2025) Rare Care Matters: the struggle to access diagnosis and care for rare autoimmune rheumatic disease patients. Available at: rairda.org (accessed 10 December 2025).
Royal College of Physicians (2022) The diagnosis of fibromyalgia syndrome. Royal College of Physicians, London. Available at: https://rcp.ac.uk/fibromyalgia-guidelines (accessed 10 December 2025).
19.
SloanMWincupCHarwoodR, et al. (2024) Prevalence and identification of neuropsychiatric symptoms in systemic autoimmune rheumatic diseases: an international mixed methods study. Rheumatology63(5): 1259–1272. DOI: 10.1093/rheumatology/kead369.
